These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36170034)

  • 1. Drug clearance by aldehyde oxidase: can we avoid clinical failure?
    Toselli F; Golding M; Nicolaï J; Gillent E; Chanteux H
    Xenobiotica; 2022 Aug; 52(8):890-903. PubMed ID: 36170034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development.
    Gajula SNR; Nathani TN; Patil RM; Talari S; Sonti R
    Drug Metab Rev; 2022 Nov; 54(4):427-448. PubMed ID: 36369949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Laboratory-Specific Scaling Factor to Predict the In Vivo Human Clearance of Aldehyde Oxidase Substrates.
    De Sousa Mendes M; L Orton A; Humphries HE; Jones B; Gardner I; Neuhoff S; Pilla Reddy V
    Drug Metab Dispos; 2020 Nov; 48(11):1231-1238. PubMed ID: 32893186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
    Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
    Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
    Crouch RD; Hutzler JM; Daniels JS
    Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde oxidase and its role as a drug metabolizing enzyme.
    Dalvie D; Di L
    Pharmacol Ther; 2019 Sep; 201():137-180. PubMed ID: 31128989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
    Strelevitz TJ; Orozco CC; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery.
    Manevski N; King L; Pitt WR; Lecomte F; Toselli F
    J Med Chem; 2019 Dec; 62(24):10955-10994. PubMed ID: 31385704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and human exposure prediction of two aldehyde oxidase-mediated metabolites of a methylquinoline-containing drug candidate.
    Li AC; Cui D; Yu E; Dobson K; Hellriegel ET; Robertson P
    Xenobiotica; 2019 Mar; 49(3):302-312. PubMed ID: 29473769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Aldehyde Oxidase in the Metabolic Clearance of Substituted Benzothiazoles.
    Teffera Y; Liu J; Krolikowski P; Zhao Z
    Drug Metab Lett; 2021; 14(2):126-136. PubMed ID: 34818997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase B oxidizes a novel multikinase inhibitor KW-2449 to its iminium ion and aldehyde oxidase further converts it to the oxo-piperazine form in human.
    Hosogi J; Ohashi R; Maeda H; Tashiro S; Fuse E; Yamamoto Y; Kuwabara T
    Drug Metab Pharmacokinet; 2017 Oct; 32(5):255-264. PubMed ID: 28751116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
    Zientek M; Jiang Y; Youdim K; Obach RS
    Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde Oxidase.
    Paragas EM; Choughule K; Jones JP; Barr JT
    Methods Mol Biol; 2021; 2342():257-284. PubMed ID: 34272698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes.
    Akabane T; Gerst N; Masters JN; Tamura K
    Xenobiotica; 2012 Sep; 42(9):863-71. PubMed ID: 22448773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Exposure in a First-in-Man Study Due to Aldehyde Oxidase Metabolism: Investigated by Use of 14C-microdose, Humanized Mice, Monkey Pharmacokinetics, and In Vitro Methods.
    Jensen KG; Jacobsen AM; Bundgaard C; Nilausen DØ; Thale Z; Chandrasena G; Jørgensen M
    Drug Metab Dispos; 2017 Jan; 45(1):68-75. PubMed ID: 27737930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for a comprehensive understanding of metabolism by aldehyde oxidase.
    Hutzler JM; Obach RS; Dalvie D; Zientek MA
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):153-68. PubMed ID: 23231678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu
    Crouch RD; Blobaum AL; Felts AS; Conn PJ; Lindsley CW
    Drug Metab Dispos; 2017 Dec; 45(12):1245-1259. PubMed ID: 28939686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.
    Argikar UA; Potter PM; Hutzler JM; Marathe PH
    AAPS J; 2016 Nov; 18(6):1391-1405. PubMed ID: 27495117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting intrinsic clearance for drugs and drug candidates metabolized by aldehyde oxidase.
    Jones JP; Korzekwa KR
    Mol Pharm; 2013 Apr; 10(4):1262-8. PubMed ID: 23363487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382.
    Hutzler JM; Cerny MA; Yang YS; Asher C; Wong D; Frederick K; Gilpin K
    Drug Metab Dispos; 2014 Oct; 42(10):1751-60. PubMed ID: 25035284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.